BioNTech SE

Stocks

BNTX

US09075V1026

Market Closed - Nasdaq 04:00:00 2026-10-02 pm EDT			5-day change	1st Jan Change
96.90 ^USD	+0.05%		-1.64%	+1.79%

Sep. 11	Biontech Insider Sold Shares Worth $1,974,287, According to a Recent SEC Filing	MT
Sep. 10	European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading	MT

Transcript : BioNTech SE - Special Call

Published on 11/17/2025 at 01:08 pm EST - Modified on 11/17/2025 at 05:40 pm EST

S&P Capital IQ

Presenter Speech
Unknown Executive (Executives)

[Audio Gap] by Annemarie Hanekamp, our Chief Commercial Officer. So with that, I'm excited to hand over to Ugur and welcome him to the stage to talk to

This article is reserved for our subscribers.

Subcribe
to read the article

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

Latest news about BioNTech SE

Sep. 11	Biontech Insider Sold Shares Worth $1,974,287, According to a Recent SEC Filing	MT
Sep. 10	European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading	MT
Sep. 08	Biontech Insider Sold Shares Worth $7,889,055, According to a Recent SEC Filing	MT
Sep. 08	European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading	MT
Sep. 08	BMO Capital Downgrades BioNTech to Market Perform From Outperform, Adjusts PT to $105 From $128	MT
Sep. 04	European Equities Traded in the US as American Depositary Receipts Marginally Higher in Friday Trading	MT
Sep. 04	BioNTech SE : Goldman Sachs gives a Buy rating	ZD
Sep. 01	GSK Moves mRNA Flu Vaccine Candidate to Late-Stage Trial	DJ
Aug. 28	Health Care Down, But not by Much, on Rotation Out of Rate-Sensitive Areas - Health Care Roundup	DJ
Aug. 28	BioNTech SE And Genentech Terminate Phase 2 Clinical Trial Collaboration For Autogene Cevumeran In Resected Colorectal Cancer	CI
Aug. 28	Sector Update: Healthcare Stocks Decline Late Afternoon	MT
Aug. 28	BioNTech Terminates Phase 2 Colorectal Cancer Clinical Trial; Shares Fall	MT
Aug. 28	Upbeat Economic Outlook Buoys Swiss Market Index	MT
Aug. 28	Germany's DAX Index Extends Gains; BioNTech Tumbles After Scrapping Cancer Vaccine Trial	MT
Aug. 28	Top Midday Stories: Warsh Says Inflation Data 'Concerning'; Advent, Stripe Drop $50 Billion Bid to Buy PayPal	MT